Autopsy report · NCT01723397

Effect of Nasaleze on Nasal Challenge With Allergen

“Poor recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 8 months before it stopped.
• 14 participants enrolled.
• Results were posted on the registry 2 years 3 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

University of Chicago

Sponsor type

University, hospital or other

Conditions

Allergic Rhinitis

Interventions

Nasaleze Spray; Placebo spray; Allergen

Participants

14

Sites

1

Countries

United States

Trials that died the same way

• Pilot RCT Evaluating a One Stop Vein Clinic
  “Very poor recruitment” (95% match in meaning)
• Prospective Evaluation of Quality of Life in Patients With Acute Colonic Diverticular Disease
  “poor recruitment status” (93% match in meaning)
• A Trial of Intravenous Calcium and Myocardial Diastolic Dysfunction During Separation From Cardiopulmonary Bypass
  “Inadequate recruitment” (92% match in meaning)
• Eurartesim® in Patients With Imported Uncomplicated Plasmodium Vivax Malaria
  “Low recruitment” (91% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.